India Astrazeneca
-
{
- All
- News
- Videos
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca Legal Notice To Serum Institute Over Vaccine Delays
Adar Poonawalla's Serum Institute of India (SII), the maker of coronavirus vaccine Covishield in India, has reportedly been served a legal notice by AstraZeneca over vaccine supply delays.
-
India Delays Big Exports Of AstraZeneca Shot As Infections Surge: Report
India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), the world's biggest vaccine-maker, to meet domestic demand as infections rise, two sources told Reuters.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
Will Send Covid Vaccine To Canada In "Less Than A Month": Serum Institute
The Serum Institute of India will ship the Oxford University/AstraZeneca COVID-19 vaccine to Canada in less than one month, Serum's chief executive said on Monday.
-
India Backs AstraZeneca, Orders 10 Million New Doses
India said on Tuesday it had no concerns over the efficacy of the AstraZeneca COVID-19 vaccine despite South Africa putting it on hold, and ordered 10 million more doses of the shot for its own huge immunisation campaign.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca Legal Notice To Serum Institute Over Vaccine Delays
Adar Poonawalla's Serum Institute of India (SII), the maker of coronavirus vaccine Covishield in India, has reportedly been served a legal notice by AstraZeneca over vaccine supply delays.
-
India Delays Big Exports Of AstraZeneca Shot As Infections Surge: Report
India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), the world's biggest vaccine-maker, to meet domestic demand as infections rise, two sources told Reuters.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
Will Send Covid Vaccine To Canada In "Less Than A Month": Serum Institute
The Serum Institute of India will ship the Oxford University/AstraZeneca COVID-19 vaccine to Canada in less than one month, Serum's chief executive said on Monday.
-
India Backs AstraZeneca, Orders 10 Million New Doses
India said on Tuesday it had no concerns over the efficacy of the AstraZeneca COVID-19 vaccine despite South Africa putting it on hold, and ordered 10 million more doses of the shot for its own huge immunisation campaign.
